Sign in

Moez Dawood

@moezdawood.bsky.social
128 followers 302 following 10 posts
PostsRepliesMedia
Reposted by Moez Dawood
From the Labs at Baylor College of Medicine @bcmfromthelabs.bsky.social · 20/11/2025
Check major accomplishments of @gregor-research.bsky.social. @eurekalert.bsky.social @bcmhgsc.bsky.social @moezdawood.bsky.social #LupskiLab @sedlazeck.bsky.social @poseypod.bsky.social @bcmhouston.bsky.social S. Montgomery @stanfordmedicine.bsky.social @nature.com www.eurekalert.org/news-release...
023
Reposted by Moez Dawood
From the Labs at Baylor College of Medicine @bcmfromthelabs.bsky.social · 18/11/2025
Learn about the major accomplishments of @gregor-research.bsky.social. R. Gibbs, @bcmhgsc.bsky.social @moezdawood.bsky.social #LupskiLab @sedlazeck.bsky.social @poseypod.bsky.social @bcmhouston.bsky.social S. Montgomery @stanfordmedicine.bsky.social @nature.com blogs.bcm.edu/2025/11/18/f...
blogs.bcm.edu
How GREGoR Consortium is advancing the diagnostics of rare diseases
Learn about the major accomplishments of the consortium’s first five years and the frontiers in genomic medicine that researchers will tackle next.
024
Reposted by Moez Dawood
OpenCravat.bsky.social @opencravat.bsky.social · 15/08/2025
@moezdawood.bsky.social created the AllofUs 250k annotator for OpenCRAVAT to improve genomic research by integrating diverse data, including ancestry-specific allele frequencies. You can read more about Moez's experience developing the annotator here: www.opencravat.org/bringing-gen... #opensource
opencravat.org
Bringing Genetic Diversity to the Forefront: Moez Dawood on the AllofUs 250k Annotator for OpenCRAVAT
Moez Dawood, an MD/PhD student at Baylor College of Medicine, has recently developed the AllofUs 250k annotator for OpenCRAVAT, a genomic annotation platform designed to handle both single variant…
042
Reposted by Moez Dawood
Sriram Pendyala @treependyala.bsky.social · 07/07/2025
🚨 Most variant screens measure growth or abundance. What do they miss? That variants impact a spectrum of protein and cellular phenotypes. Variant in situ sequencing (VIS-seq) finds what’s missing: image cells 🔬 first, decode later, revealing multi-scale phenotypes for thousands of variants.👇 1/9
35118
Reposted by Moez Dawood
Jeff Calhoun @calhoujd.bsky.social · 25/03/2025
Excited to share our @varianteffect.bsky.social CVI workstream preprint! Herein, we discuss important considerations for integration of multiplex functional data to generate a single score set and how this is likely to impact variant classification now and in the future arxiv.org/abs/2503.18810
arxiv.org
Combining multiplexed functional data to improve variant classification
With the surge in the number of variants of uncertain significance (VUS) reported in ClinVar in recent years, there is an imperative to resolve VUS at scale. Multiplexed assays of variant effect (MAVE...
1157
Reposted by Moez Dawood
Suja Jagannathan @rnabiologist.bsky.social · 25/03/2025
Excited to have this out as a preprint! It was a pleasure to work with @calhoujd.bsky.social and all the coauthors brought together by @varianteffect.bsky.social.
1105
Moez Dawood @moezdawood.bsky.social · 21/03/2025
🚨 Big news at #ACMG2025! 🚨 Today we’re announcing global democratization of deidentified allele count + frequency data with population breakdown from the first ~250k short-read WGS in All of Us designed to plug straight into clinical workflows. It is ~1.1 billion unique variants! 🧬💡 🧵 (1/4)
164
Reposted by Moez Dawood
GREGoR Consortium @gregor-research.bsky.social · 20/03/2025
At #ACMG25? 🧬 Don't miss @moezdawood.bsky.social presenting "GREGoR: Accelerating Genomics for Rare Diseases" Friday 3/20 at 1:30pm PST Platform Session 8 Preprint here: pubmed.ncbi.nlm.nih.gov/39764392/ #Genomics #Research #Collaboration @gregor-research.bsky.social
pubmed.ncbi.nlm.nih.gov
GREGoR: Accelerating Genomics for Rare Diseases - PubMed
Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA seq...
032
Reposted by Moez Dawood
Yun S. Song @yun-s-song.bsky.social · 04/03/2025
In our updated TraitGym preprint (w/ @gonzalobenegas.bsky.social & Gökcen Eraslan), we evaluate Evo 2 on regulatory variants associated with human traits. We see marked performance gains with scale on Mendelian traits, although still a bit behind alignment-based methods. doi.org/10.1101/2025... 1/n
13213
Reposted by Moez Dawood
Leandros Boukas @leandrosboukas.bsky.social · 27/02/2025
I'm very happy to share our latest work with Seth Berger and the UCI-GREGoR team. Using long-read sequencing, we can detect de novo variants *without* sequencing both parents. We call our method duoNovo. preprint: www.medrxiv.org/content/10.1... R package: github.com/sbergercnmc/... (1/n)
163
Reposted by Moez Dawood
Mallory Freeberg @malloryfreeberg.bsky.social · 27/02/2025
#standards, #mechanisms, & #identifiers - oh my! Just in time for #RareDisease Day, the @gene2phenotype.bsky.social website has a fresh look & new features to improve access to gene-disease models. 🧬💻 👉 Updated website: www.ebi.ac.uk/gene2phenoty... 👉 Why it matters: www.ebi.ac.uk/about/news/u...
064
Reposted by Moez Dawood
Rachel Ungar @raungar.bsky.social · 24/01/2025
Interested in rare variants, the X-chromosome, sex-differences, pharmacogenetics, or transcription factors? You might be interested in our new manuscript where we identified >700 functional rare variants with a difference in effect by sex in GTEx! bit.ly/x_rv_sex #genomics #multiomics 💻🧬
biorxiv.org
Functional impact of rare variants and sex across the X-chromosome and autosomes
The human X-chromosome contains hundreds of genes and has well-established impacts on sex differences and traits. However, the X-chromosome is often excluded from many genetic analyses, limiting broad...
1133
Reposted by Moez Dawood
Magdalena Skipper @magdalenaskipper.bsky.social · 24/01/2025
A map of the rubisco biochemical landscape. Rubisco is the main CO2-fixing enzyme of the biosphere yet its kinetics are slow. This work shows that non-trivial biochemical changes are readily accessible pointing the way to new engineering ways 🧪 @nature.com www.nature.com/articles/s41...
nature.com
A map of the rubisco biochemical landscape - Nature
A massively parallel assay developed to map the essential photosynthetic enzyme rubisco showed that non-trivial biochemical changes and improvements in CO2 affinity are possible, signposting further e...
063
Reposted by Moez Dawood
Jeff Calhoun @calhoujd.bsky.social · 10/01/2025
Proud to introduce curated loci prime editing (cliPE)! It is a generalizable and accessible platform to characterize many genetic variants in a gene of interest 1/11 arxiv.org/abs/2501.04822
arxiv.org
Curated loci prime editing (cliPE) for accessible multiplexed assays of variant effect (MAVEs)
Multiplexed assays of variant effect (MAVEs) perform simultaneous characterization of many variants. Prime editing has been recently adopted for introducing many variants in their native genomic conte...
131
Reposted by Moez Dawood
Maggie Arriaga @maggie-arriaga.bsky.social · 07/01/2025
What if one variant can cause splicing outliers transcriptome-wide? In our preprint, we show how examining transcriptome-wide patterns of splicing outliers can both diagnose individuals with rare spliceopathies and uncover novel disease-gene relationships! (www.medrxiv.org/content/10.1...)
medrxiv.org
Transcriptome-wide outlier approach identifies individuals with minor spliceopathies
RNA-sequencing has improved the diagnostic yield of individuals with rare diseases. Current analyses predominantly focus on identifying outliers in single genes that can be attributed to cis-acting va...
12711
Reposted by Moez Dawood
Stephen Montgomery @sbmontgom.bsky.social · 20/12/2024
GREGoR Consortium preprint online! With the R02 release, there is a huge amount of genomics, multi-omics and phenotype data from the hardest-to-solve rare disease cases.
032
Moez Dawood @moezdawood.bsky.social · 20/12/2024
🚨 Excited to announce the Marker paper for the GREGoR Consortium! arxiv.org/abs/2412.14338 Accelerating #RareDisease diagnostics with cutting-edge #Genomics and global data sharing of omics and deep phenotyping from ~7500 individuals on NHGRI AnVIL and much more to come! 🧬
arxiv.org
GREGoR: Accelerating Genomics for Rare Diseases
Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA seq...
11712
Reposted by Moez Dawood
Claudia Carvalho @claucarvalho.bsky.social · 18/12/2024
Genomic duplications involving MECP2 are surprisingly complex and affect almost half of patients. Importantly, complexity contributes to gene expression and clinical variability. @pnrigenetics.bsky.social @gregor-research.bsky.social genomemedicine.biomedcentral.com/articles/10....
genomemedicine.biomedcentral.com
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression - Genome Medicine
Background MECP2 Duplication Syndrome, also known as X-linked intellectual developmental disorder Lubs type (MRXSL; MIM: 300260), is a neurodevelopmental disorder caused by copy number gains spanning ...
034
Moez Dawood @moezdawood.bsky.social · 08/12/2024
Paper came out this past week! Using MAVEs to reduce variant classification disparities in underrepresented populations and demonstrating AI bias in computational predictors rdcu.be/d2kCn Previous tweetorial: x.com/MoezDawood/s... Previous post by @ee-reh-neh.bsky.social: bsky.app/profile/ee-r...
rdcu.be
Using multiplexed functional data to reduce variant classification inequities in underrepresented populations
055
Reposted by Moez Dawood
Irene Gallego Romero @ee-reh-neh.bsky.social · 19/04/2024
New work! Wherein we (as in, the AVE ODIC working group) looked at clinical variant classification across genetic ancestry groups in gnomAD and AoU and what we found... is exactly what you might expect, after decades of Eurocentric research. But we also show there's a better way forward! 🧬🖥️
2188